These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1681109)

  • 1. Do anti-P-glycoprotein antibodies have a future in the circumvention of multidrug resistance?
    Beck WT
    J Natl Cancer Inst; 1991 Oct; 83(19):1364-6. PubMed ID: 1681109
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody-directed therapy of multidrug-resistant tumor cells.
    Efferth T; Volm M
    Med Oncol Tumor Pharmacother; 1992; 9(1):11-9. PubMed ID: 1285219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective growth-inhibition of multidrug-resistant CHO-cells by the monoclonal antibody 265/F4.
    Efferth T; Lathan B; Volm M
    Br J Cancer; 1991 Jul; 64(1):87-9. PubMed ID: 1677260
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of P-glycoprotein in human leukemias using monoclonal antibodies.
    Mattern J; Efferth T; Bak M; Ho AD; Volm M
    Blut; 1989 Apr; 58(4):215-7. PubMed ID: 2565123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circumvention of multidrug resistance with anti-P-glycoprotein antibodies: clinical potential or experimental artifact?
    Beck WT
    J Natl Cancer Inst; 1995 Jan; 87(2):73-5. PubMed ID: 7707392
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of multidrug-resistant human tumor growth in athymic mice by anti-P-glycoprotein monoclonal antibodies.
    Tsuruo T; Hamada H; Sato S; Heike Y
    Jpn J Cancer Res; 1989 Jul; 80(7):627-31. PubMed ID: 2571602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: Circumvention of multi-drug resistance with anti-P-glycoprotein antibodies: clinical potential or experimental artifact?
    Baccarani M
    J Natl Cancer Inst; 1995 Jun; 87(11):845-6. PubMed ID: 7791235
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhancement of reversing effect of cyclosporin A on vincristine resistance by anti-P-glycoprotein monoclonal antibody MRK-16.
    Naito M; Tsuge H; Kuroko C; Tomida A; Tsuruo T
    Jpn J Cancer Res; 1993 May; 84(5):489-92. PubMed ID: 8100562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of recombinant P-glycoprotein fragments to produce antibodies to the multidrug transporter.
    Tanaka S; Currier SJ; Bruggemann EP; Ueda K; Germann UA; Pastan I; Gottesman MM
    Biochem Biophys Res Commun; 1990 Jan; 166(1):180-6. PubMed ID: 1967936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary studies of a monoclonal antibody raised to the over expressed plasma membrane associated glycoprotein of a multidrug resistant cell line.
    Moran E; Redmond A; Clynes M
    Biochem Soc Trans; 1992 Feb; 20(1):58S. PubMed ID: 1353037
    [No Abstract]   [Full Text] [Related]  

  • 11. P-glycoprotein expression in primary breast cancer detected by immunocytochemistry with two monoclonal antibodies.
    Wishart GC; Plumb JA; Going JJ; McNicol AM; McArdle CS; Tsuruo T; Kaye SB
    Br J Cancer; 1990 Nov; 62(5):758-61. PubMed ID: 1978783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic-affinity cell sorting of human multidrug-resistant cells.
    Padmanabhan R; Tsuruo T; Kane SE; Willingham MC; Howard BH; Gottesman MM; Pastan I
    J Natl Cancer Inst; 1991 Apr; 83(8):565-9. PubMed ID: 1672384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug resistance and its circumvention.
    Beck WT
    Eur J Cancer; 1990 Apr; 26(4):513-5. PubMed ID: 1972629
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of P-glycoprotein in human tumours.
    Baker RM; Fredericks WJ; Chen YF
    Cancer Invest; 1990; 8(2):255-6. PubMed ID: 1976033
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunohistochemical analysis of pulmonary and pleural tumors with the monoclonal antibody HYB-612 directed against the multidrug resistance (MDR-1) gene product, P-glycoprotein.
    Radosevich JA; Robinson PG; Rittmann-Grauer LS; Wilson B; Leung JP; Maminta ML; Warren W; Rosen ST; Gould VE
    Tumour Biol; 1989; 10(5):252-7. PubMed ID: 2479079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal anti-P-glycoprotein antibody-dependent killing of multidrug-resistant tumor cells by human mononuclear cells.
    Heike Y; Hamada H; Inamura N; Sone S; Ogura T; Tsuruo T
    Jpn J Cancer Res; 1990 Nov; 81(11):1155-61. PubMed ID: 1979977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P-glycoprotein and multidrug resistance.
    Skubitz KM
    Am J Clin Pathol; 1990 Jan; 93(1):156-7. PubMed ID: 1967202
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody.
    Mechetner EB; Roninson IB
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5824-8. PubMed ID: 1352877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug resistance and P-glycoprotein expression.
    Ling V
    Ann N Y Acad Sci; 1987; 507():7-8. PubMed ID: 2894794
    [No Abstract]   [Full Text] [Related]  

  • 20. Reversal of drug resistance in a human colon cancer xenograft expressing MDR1 complementary DNA by in vivo administration of MRK-16 monoclonal antibody.
    Pearson JW; Fogler WE; Volker K; Usui N; Goldenberg SK; Gruys E; Riggs CW; Komschlies K; Wiltrout RH; Tsuruo T
    J Natl Cancer Inst; 1991 Oct; 83(19):1386-91. PubMed ID: 1681110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.